Studies of these signaling pathways have greatly increased our understanding of the biology and clinical behavior of Glioblastoma. An integrated view of signal transduction will provide a more useful approach in designing novel therapies for this devastating disease. In this review, we summarize the current understanding of Glioblastoma signaling pathways with a focus on potential molecular targets for anti-signaling molecular therapies 1).

1)
Nakada M, Kita D, Watanabe T, Hayashi Y, Teng L, Pyko IV, Hamada J. Aberrant signaling pathways in glioma. Cancers (Basel). 2011 Aug 10;3(3):3242-78. doi: 10.3390/cancers3033242. PMID: 24212955; PMCID: PMC3759196.